Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.5516
-0.0094 (-1.68%)
At close: Sep 15, 2026, 4:00 PM EDT
0.5626
+0.0110 (1.99%)
After-hours: Sep 15, 2026, 7:30 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $153.23 million as of September 15, 2026. Its market cap has decreased by -34.37% in one year.
Market Cap
153.23M
Enterprise Value
140.21M
1-Year Change
-34.37%
Ranking
Category
Stock Price
$0.55
ChartMarket Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $153.23M, an increase of 23.27%. That is a compound annual growth rate of 3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 153.23M | -17.34% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 167.33M |
| Spruce Biosciences | 163.39M |
| Codexis | 162.07M |
| Corbus Pharmaceuticals Holdings | 156.28M |
| Tenaya Therapeutics | 155.37M |
| Outlook Therapeutics | 155.30M |
| Jyong Biotech | 154.41M |
| Immunic | 153.23M |